πŸ‡ΊπŸ‡Έ FDA
Patent

US 11352410

Anti-KK-LC-1 T cell receptors

granted A61KA61K2239/59A61K38/00

Quick answer

US patent 11352410 (Anti-KK-LC-1 T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2239/59, A61K38/00, A61K40/11, A61K40/32